World Heart (WHRT) Announces Milestone in Miniaturized Assist Pump Development
World Heart Corporation (Nasdaq: WHRT) announced a successful animal implant of a miniaturized, pediatric, ventricular assist device (VAD). The PediaFlow design also is the platform for a future minimally invasive adult VAD, intended to meet a large clinical need for earlier-stage heart failure patients.
Mr. Jal Jassawalla, WorldHeart's President and CEO, commented that, "WorldHeart is extremely pleased to participate in the development of this technology for infants. We are also excited about potential adaptation to a broad, adult, population with less advanced heart failure. We believe that pump miniaturization will allow implantation of the adult configuration using minimally invasive surgical techniques. This represents a complementary addition to the existing Levacor device."
Create E-mail AlertRelated Categories
Corporate NewsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
